MicroRNA-192 promotes the development of nasopharyngeal carcinoma through targeting RB1 and activating PI3K/AKT pathway

被引:17
|
作者
Huang, Qingli [1 ]
Hou, Sen [2 ]
Zhu, Xiuqing [3 ]
Liu, Shouzhou [1 ]
机构
[1] Liaocheng Peoples Hosp, Dept Otorhinolaryngol Head & Neck Surg, 67 Dongchang West Rd, Liaocheng 252000, Shandong, Peoples R China
[2] Yanggu Peoples Hosp, Dept Otolaryngol, Liaocheng, Shandong, Peoples R China
[3] Chiping Peoples Hosp, Dept Otolaryngol, Liaocheng, Shandong, Peoples R China
关键词
miR-192; Nasopharyngeal carcinoma; RB1; PI3K; AKT pathway; CELL-PROLIFERATION; RETINOBLASTOMA PROTEIN; MIR-192; SUPPRESSES; TUMOR-SUPPRESSOR; CANCER CELLS; METASTASIS; INVASION; GROWTH; APOPTOSIS; PROGRESSION;
D O I
10.1186/s12957-020-1798-y
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background The dysregulation of microRNAs (miRNAs) has been found in diseases and cancers, including microRNA-192 (miR-192). This study was designed to investigate the role of miR-192 in nasopharyngeal carcinoma (NPC) progression. Methods The expression levels of miR-192 and some genes were assessed by qRT-PCR and Western blot. The function of miR-192 was investigated through MTT, Transwell, and dual-luciferase reporter assays. Results The expression of miR-192 was increased in NPC tissues, and high miR-192 expression predicted poor prognosis in NPC patients. Functionally, upregulation of miR-192 promoted NPC cell migration, invasion, and growth. Furthermore, miR-192 activated EMT and PI3K/AKT pathway to regulate NPC progression. In addition, miR-192 directly targeted RB1 and suppressed its expression in NPC. Moreover, overexpression of RB1 weakened the promoted effect of miR-192 in NPC. Conclusion miR-192 promoted cell viability and metastasis in NPC through suppressing RB1 expression and activating PI3K/AKT pathway.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] MicroRNA-192 promotes the development of nasopharyngeal carcinoma through targeting RB1 and activating PI3K/AKT pathway
    Qingli Huang
    Sen Hou
    Xiuqing Zhu
    Shouzhou Liu
    World Journal of Surgical Oncology, 18
  • [2] SETD1A promotes the proliferation and glycolysis of nasopharyngeal carcinoma cells by activating the PI3K/Akt pathway
    Huang, Jianyi
    Fang, Jinshu
    Xu, Xiao
    Qian, Xueshen
    Zhang, Xia
    OPEN MEDICINE, 2022, 17 (01): : 1849 - 1859
  • [3] MicroRNA-215 promoted the progression of nasopharyngeal carcinoma through targeting RB1 and activating Wnt/β-catenin pathway
    Zhang, Yuanyuan
    Zhang, Hui
    Li, Xiuguo
    JOURNAL OF BUON, 2020, 25 (03): : 1579 - 1586
  • [4] MicroRNA-802 promotes the progression of osteosarcoma through targeting p27 and activating PI3K/AKT pathway
    L. F. Gao
    S. Jia
    Q. M. Zhang
    Y. F. Xia
    C. J. Li
    Y. H. Li
    Clinical and Translational Oncology, 2022, 24 : 266 - 275
  • [5] MicroRNA-802 promotes the progression of osteosarcoma through targeting p27 and activating PI3K/AKT pathway
    Gao, L. F.
    Jia, S.
    Zhang, Q. M.
    Xia, Y. F.
    Li, C. J.
    Li, Y. H.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2022, 24 (02): : 266 - 275
  • [6] APLN promotes hepatocellular carcinoma through activating PI3K/Akt pathway and is a druggable target
    Chen, Huarong
    Wong, Chi-Chun
    Liu, Dabin
    Go, Minnie Y. Y.
    Wu, Bin
    Peng, Sui
    Kuang, Ming
    Wong, Nathalie
    Yu, Jun
    THERANOSTICS, 2019, 9 (18): : 5246 - 5260
  • [7] PAQR4 promotes the development of hepatocellular carcinoma by activating PI3K/AKT pathway
    Zhao, Gang
    Shi, Xiaobao
    Sun, Zhanbo
    Zhao, Pengfei
    Lu, Zaiming
    ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2021, 53 (12) : 1602 - 1613
  • [8] Acylglycerol kinase promotes the stemness of nasopharyngeal carcinoma cells by promoting β-catenin translocation to the nucleus through activating PI3K/Akt pathway
    Zhao, Qi
    Sun, Peng
    Qin, Songbing
    Liu, Jisheng
    ENVIRONMENTAL TOXICOLOGY, 2020, 35 (12) : 1299 - 1307
  • [9] PODXL promotes malignant progression of hepatocellular carcinoma by activating PI3K/AKT pathway
    Ding, Yifeng
    Wang, Xiaoqing
    Shu, Fei
    Pan, Kehua
    Chen, Xiaohong
    Liu, Qingquan
    JOURNAL OF MOLECULAR HISTOLOGY, 2024, 55 (06) : 1107 - 1120
  • [10] LINC00963 promotes hepatocellular carcinoma progression by activating PI3K/AKT pathway
    Wu, J. -H.
    Tian, X. -Y.
    An, Q-M.
    Guan, X. -Y.
    Hao, C. -Y.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2018, 22 (06) : 1645 - 1652